Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1838)
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,400
Price
$320.92
Total Value
$449.29K
Shares Held After
126,619
% of Holdings
1.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,000
Price
$319.76
Total Value
$319.76K
Shares Held After
128,019
% of Holdings
0.8%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
200
Price
$89.04
Total Value
$17.81K
Shares Held After
97,994
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
400
Price
$89.07
Total Value
$35.63K
Shares Held After
552,540
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,016
Price
$88.03
Total Value
$177.47K
Shares Held After
98,194
% of Holdings
2.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,700
Price
$88.06
Total Value
$325.82K
Shares Held After
552,940
% of Holdings
0.7%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
4,384
Price
$87.11
Total Value
$381.89K
Shares Held After
100,210
% of Holdings
4.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
8,400
Price
$87.15
Total Value
$732.06K
Shares Held After
556,640
% of Holdings
1.5%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
900
Price
$86.25
Total Value
$77.62K
Shares Held After
104,594
% of Holdings
0.9%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,500
Price
$86.36
Total Value
$215.90K
Shares Held After
565,040
% of Holdings
0.4%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
1,698
Price
$320.99
Total Value
$545.04K
Shares Held After
98,199
% of Holdings
1.7%
SI-BONE, Inc. (SIBN)
DUNN JEFFREY W — Director
Shares
1,367
Price
$18.91
Total Value
$25.85K
Shares Held After
16,057
% of Holdings
7.8%
SI-BONE, Inc. (SIBN)
DUNN JEFFREY W — Director
Shares
18,633
Price
$18.91
Total Value
$352.31K
Shares Held After
17,424
% of Holdings
51.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
29,088
Price
$7.06
Total Value
$205.36K
Shares Held After
4,202,346
% of Holdings
0.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
29,088
Price
$7.06
Total Value
$205.36K
Shares Held After
4,202,346
% of Holdings
0.7%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
584
Price
$14.00
Total Value
$8.18K
Shares Held After
8,617
% of Holdings
6.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
21,688
Price
$98.91
Total Value
$2.15M
Shares Held After
194,440
% of Holdings
10.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
8,312
Price
$98.08
Total Value
$815.24K
Shares Held After
216,128
% of Holdings
3.7%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
3,333
Price
$37.83
Total Value
$126.08K
Shares Held After
96,412
% of Holdings
3.3%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — Chief Commercial Officer
Shares
1,746
Price
$2.26
Total Value
$3.95K
Shares Held After
449,832
% of Holdings
0.4%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — Chief Commercial Officer
Shares
1,530
Price
$2.26
Total Value
$3.46K
Shares Held After
451,578
% of Holdings
0.3%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — Chief Commercial Officer
Shares
2,390
Price
$2.26
Total Value
$5.40K
Shares Held After
453,108
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — Chief Commercial Officer
Shares
2,213
Price
$2.26
Total Value
$5.00K
Shares Held After
455,498
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science&Techn. Officer
Shares
5,863
Price
$2.26
Total Value
$13.25K
Shares Held After
316,994
% of Holdings
1.8%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science&Techn. Officer
Shares
3,618
Price
$2.26
Total Value
$8.18K
Shares Held After
322,857
% of Holdings
1.1%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science&Techn. Officer
Shares
2,121
Price
$2.26
Total Value
$4.79K
Shares Held After
326,475
% of Holdings
0.6%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science&Techn. Officer
Shares
2,643
Price
$2.26
Total Value
$5.97K
Shares Held After
328,596
% of Holdings
0.8%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
37,784
Price
$2.26
Total Value
$85.39K
Shares Held After
1,137,936
% of Holdings
3.2%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
4,098
Price
$2.26
Total Value
$9.26K
Shares Held After
1,175,720
% of Holdings
0.3%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
3,695
Price
$24.27
Total Value
$89.68K
Shares Held After
411,861
% of Holdings
0.9%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
4,933
Price
$23.13
Total Value
$114.10K
Shares Held After
415,556
% of Holdings
1.2%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
5,600
Price
$24.27
Total Value
$135.90K
Shares Held After
420,489
% of Holdings
1.3%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
7,344
Price
$23.12
Total Value
$169.78K
Shares Held After
426,089
% of Holdings
1.7%
Pulmonx Corp (LUNG)
Lehman David Aaron — General Counsel
Shares
4,827
Price
$2.26
Total Value
$10.91K
Shares Held After
361,827
% of Holdings
1.3%
Pulmonx Corp (LUNG)
Lehman David Aaron — General Counsel
Shares
3,476
Price
$2.26
Total Value
$7.86K
Shares Held After
366,654
% of Holdings
0.9%
Pulmonx Corp (LUNG)
Lehman David Aaron — General Counsel
Shares
2,224
Price
$2.26
Total Value
$5.03K
Shares Held After
370,130
% of Holdings
0.6%
Pulmonx Corp (LUNG)
Lehman David Aaron — General Counsel
Shares
3,807
Price
$2.26
Total Value
$8.60K
Shares Held After
372,354
% of Holdings
1.0%
American Well Corp (AMWL)
HIRSCHHORN MARK — Chief Financial Officer
Shares
10,751
Price
$11.80
Total Value
$126.86K
Shares Held After
228,188
% of Holdings
4.5%
American Well Corp (AMWL)
Gotlib Phyllis — President, International
Shares
3,573
Price
$11.80
Total Value
$42.16K
Shares Held After
149,181
% of Holdings
2.3%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
132
Price
$355.86
Total Value
$46.97K
Shares Held After
0
% of Holdings
100.0%
American Well Corp (AMWL)
McNeice Paul Francis — Chief Accounting Officer
Shares
112
Price
$11.80
Total Value
$1.32K
Shares Held After
9,739
% of Holdings
1.1%
QUEST DIAGNOSTICS INC (DGX)
Davis J. E. — Director
Shares
10,000
Price
$242.72
Total Value
$2.43M
Shares Held After
122,423
% of Holdings
7.6%
Orthofix Medical Inc. (OFIX)
Fisher Patrick — President, Global Limb Recon
Shares
150
Price
$9.39
Total Value
$1.41K
Shares Held After
51,069
% of Holdings
0.3%
Moderna, Inc. (MRNA)
Klinger Shannon Thyme — Chief Legal Officer
Shares
3,471
Price
$139.95
Total Value
$485.77K
Shares Held After
74,129
% of Holdings
4.5%
Perspective Therapeutics, Inc. (CATX)
Lantheus Holdings, Inc. — 10% Owner
Shares
35,769
Price
$3.12
Total Value
$111.57K
Shares Held After
11,563,425
% of Holdings
0.3%
Tenon Medical, Inc. (TNON)
HRT FINANCIAL LP — 10% Owner
Shares
1,790
Price
$4.57
Total Value
$8.18K
Shares Held After
2,244
% of Holdings
79.8%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
16,141
Price
$26.36
Total Value
$425.51K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
13,309
Price
$106.74
Total Value
$1.42M
Shares Held After
4,000
% of Holdings
76.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
7,215
Price
$106.25
Total Value
$766.59K
Shares Held After
17,309
% of Holdings
29.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
2,600
Price
$105.19
Total Value
$273.49K
Shares Held After
24,524
% of Holdings
9.6%
Showing 251–300 of 1838 transactions (page 6 of 37)